ADA and rheumatoid arthritis: We separated monocytes from RA patients who received MTX alone (n = 5; 4 of them non-responders) and those who received monoclonal anti-TNF antibodies (ADA or infliximab [IFX]) (n = 4; 2 of them non-responders).